share_log

吉林长龙药业发布前三季度业绩 股东应占溢利1.33亿元同比增长27.36%

Jilin Changlong Pharmaceutical announced the first three quarter results, profit attributable to shareholders of 133 million yuan, up 27.36% year-on-year

新浪港股 ·  Nov 14, 2023 19:26

Jilin Changlong Pharmaceutical (08049) announced results for the first three quarters of the nine months ended September 30, 2023, with a turnover of 593 million yuan (RMB, same below), a year-on-year decrease of 0.1%; profit attributable to equity holders of 133 million yuan, an increase of 27.36% over the previous year; and profit per share of 23.79 points.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment